skip navigation

Skip Nav

Clinical Guidelines Portal

skip navigation

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

HPV

(Last updated:11/1/2012; last reviewed:11/1/2012)

Human Papillomavirus Disease
Member Financial Disclosure
Company Relationship
Brown, Darron
Indiana University School of Medicine Bioscience Vaccines, Inc Advisory Board
Merck Advisory Board, Honoraria, Patent, Speaker’s Bureau
PDS, Inc. Advisory Board
Cu-Uvin, Susan*
Brown University
CONRAD Advisory Board
Dunne, Eileen
Centers for Disease Control and Prevention
None N/A
Massad, L. Stewart 
Washington University School of Medicine
None N/A
Moscicki, Anna Barbara
University of California, San Francisco
BD Sciences Consultant, Honoraria
GenProbe Research Support
GlaxoSmithKline
Honoraria, Research Support, Travel Support
Merck Advisory Board, Honoraria
Palefsky, Joel
University of California, San Francisco
Aura Biosciences
Advisory Board, Travel Support
Merck Advisory Board, Consultant, Research Support, Travel Support
Pharmajet
Advisory Board
Strickler, Howard
Albert Einstein College of Medicine
GlaxoSmithKline
Other
Wilkin, Timothy
Weill Cornell Medical College
Gilead Research Support
Merck Research Support
Pfizer Consultant
Quest Diagnostics Consultant
Tibotec Research Support
ViiV Research Support
*Group lead

Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.